IL44135A - Anticancer medicament containing human serum - Google Patents
Anticancer medicament containing human serumInfo
- Publication number
- IL44135A IL44135A IL44135A IL4413574A IL44135A IL 44135 A IL44135 A IL 44135A IL 44135 A IL44135 A IL 44135A IL 4413574 A IL4413574 A IL 4413574A IL 44135 A IL44135 A IL 44135A
- Authority
- IL
- Israel
- Prior art keywords
- serum
- medicament
- hepatitis
- blood
- antigen
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 title claims abstract 15
- 239000003814 drug Substances 0.000 title claims abstract 8
- 230000001093 anti-cancer Effects 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 claims abstract 7
- 102000036639 antigens Human genes 0.000 claims abstract 7
- 108091007433 antigens Proteins 0.000 claims abstract 7
- 206010019799 Hepatitis viral Diseases 0.000 claims abstract 6
- 210000004369 blood Anatomy 0.000 claims abstract 6
- 239000008280 blood Substances 0.000 claims abstract 6
- 201000001862 viral hepatitis Diseases 0.000 claims abstract 6
- 241000700605 Viruses Species 0.000 claims abstract 5
- 206010028980 Neoplasm Diseases 0.000 claims abstract 4
- 201000011510 cancer Diseases 0.000 claims abstract 4
- 208000006454 hepatitis Diseases 0.000 claims abstract 4
- 231100000283 hepatitis Toxicity 0.000 claims abstract 4
- 244000052616 bacterial pathogen Species 0.000 claims abstract 3
- 230000001717 pathogenic effect Effects 0.000 claims abstract 3
- 206010023126 Jaundice Diseases 0.000 claims abstract 2
- 102000003929 Transaminases Human genes 0.000 claims abstract 2
- 108090000340 Transaminases Proteins 0.000 claims abstract 2
- 208000015181 infectious disease Diseases 0.000 claims abstract 2
- 230000002458 infectious effect Effects 0.000 claims abstract 2
- 230000001143 conditioned effect Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 241001515942 marmosets Species 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32432—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7305741A FR2218091B1 (de) | 1973-02-19 | 1973-02-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL44135A0 IL44135A0 (en) | 1974-06-30 |
| IL44135A true IL44135A (en) | 1976-12-31 |
Family
ID=9115016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL44135A IL44135A (en) | 1973-02-19 | 1974-02-04 | Anticancer medicament containing human serum |
Country Status (13)
| Country | Link |
|---|---|
| AT (1) | AT339473B (de) |
| AU (1) | AU6575874A (de) |
| BE (1) | BE810112A (de) |
| DE (1) | DE2404983A1 (de) |
| ES (1) | ES423245A1 (de) |
| FR (1) | FR2218091B1 (de) |
| GB (1) | GB1465553A (de) |
| IL (1) | IL44135A (de) |
| LU (1) | LU69412A1 (de) |
| MC (1) | MC1000A1 (de) |
| NL (1) | NL7401983A (de) |
| OA (1) | OA04602A (de) |
| ZA (1) | ZA74655B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2685870B1 (fr) * | 1992-01-03 | 1995-07-07 | Soussan Andre | Medicament anticancereux. |
-
1973
- 1973-02-19 FR FR7305741A patent/FR2218091B1/fr not_active Expired
-
1974
- 1974-01-24 BE BE140133A patent/BE810112A/xx unknown
- 1974-01-31 ZA ZA00740655A patent/ZA74655B/xx unknown
- 1974-02-01 DE DE2404983A patent/DE2404983A1/de active Pending
- 1974-02-04 IL IL44135A patent/IL44135A/en unknown
- 1974-02-08 MC MC1090A patent/MC1000A1/fr unknown
- 1974-02-13 NL NL7401983A patent/NL7401983A/xx not_active Application Discontinuation
- 1974-02-14 ES ES0423245A patent/ES423245A1/es not_active Expired
- 1974-02-18 LU LU69412A patent/LU69412A1/xx unknown
- 1974-02-18 AT AT129774A patent/AT339473B/de not_active IP Right Cessation
- 1974-02-19 OA OA55124A patent/OA04602A/xx unknown
- 1974-02-19 AU AU65758/74A patent/AU6575874A/en not_active Expired
- 1974-02-19 GB GB748274A patent/GB1465553A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU6575874A (en) | 1975-08-21 |
| LU69412A1 (de) | 1974-05-29 |
| ES423245A1 (es) | 1976-05-01 |
| BE810112A (fr) | 1974-05-16 |
| GB1465553A (en) | 1977-02-23 |
| AT339473B (de) | 1977-10-25 |
| FR2218091B1 (de) | 1976-07-02 |
| IL44135A0 (en) | 1974-06-30 |
| DE2404983A1 (de) | 1974-10-17 |
| ZA74655B (en) | 1975-09-24 |
| FR2218091A1 (de) | 1974-09-13 |
| NL7401983A (de) | 1974-08-21 |
| MC1000A1 (fr) | 1974-10-18 |
| ATA129774A (de) | 1977-02-15 |
| OA04602A (fr) | 1980-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gallin et al. | Chemotactic activity in dialyzable transfer factor | |
| Suciu-Foca et al. | Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer | |
| Winston et al. | Pneumococcal vaccination of recipients of bone marrow transplants | |
| Bass | Behavior of eosinophil leukocytes in acute inflammation. I. Lack of dependence on adrenal function. | |
| WO1985005034A1 (en) | Compositions for the allevation, treatment and diagnosis of arthritic disease and related conditions | |
| Cassel et al. | Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses | |
| Thomas Jr et al. | Demonstration of Infectious Hepatitis Virus in Presymptomatic Period after Transfer by Transfusion.∗ | |
| Francis Jr | Differentiation of Influenza A and Influenza B by the Complement-Fixation Reaction. | |
| Turner et al. | Hemagglutinating virus isolated from cat scratch disease | |
| IL44135A (en) | Anticancer medicament containing human serum | |
| Penhale et al. | The immunodepressive effect of rinderpest virus | |
| Schrek et al. | Cytotoxicity of a homologous immune serum to a transplantable rat tumor by the method of unstained cell counts | |
| Hayes et al. | Influence of propranolol on weight and salt and water homoeostasis in chronic liver disease | |
| Phillips et al. | Passive Transfer of Immunity to Sarcoma I with Serum. | |
| Aronson et al. | The comparison of some tuberculins in BCG-vaccinated and unvaccinated persons | |
| Weir et al. | Intrinsic factor secretion in response to continuous histamine infusion | |
| Hill et al. | Sedimentation behavior of serum lactic dehydrogenase | |
| Graw Jr et al. | Priapism in a child with chronic granulocytic leukemia | |
| Sorensen et al. | Antigenic fractions specific for Histoplasma capsulatum in the complement fixation reaction | |
| Kirk et al. | Effect of oral thiamine administration on thiamine content of the stool. | |
| Freestone et al. | Transient monoclonal gammopathy in hydralazine-induced lupus erythematosus | |
| Ireton et al. | The covert liver disease of drug addicts | |
| JPS63316736A (ja) | 抗レトロウィルス剤 | |
| Kamat et al. | Typhoid: Clinical picture and response to chloramphenicol: Prospective study in Bombay (1972) | |
| Driessen et al. | Haemadsorption in vaccinia-infected tube tissue cultures |